EP Device Implant v3.0 Education
Modernizing Reporting and the NCDR User Experience
1224 - Sequence # 7800 | PCI Status
1224 - Untangling the STS Isolated Tricuspid Valve Surgery Risk Calculator in the Tricuspid Module
1224 - Sequence # 12153/9002 | Intra or Post Procedure Events/Occurred
1224 - Prior Percutaneous Coronary Intervention | Prior Coronary Artery Bypass Graft
1224 - Procedures Performed
1224 - Sequence # 15714 | Pulmonary Vein Isolation
1224 - Sequence # 10116 | Cardiac Rehab Referral
Electrophysiology (EP) Accreditation Overview (Non-CE)
Opening Plenary/The Ralph G. Brindis Keynote - 2024 Quality Summit Presentation (Non-CE)
Best Practices for Understanding LAAO Procedures and Associated Data Elements for Abstracting Effectively- 2024 Quality Summit Presentation (Non-CE)
Performance Improvement Initiatives Optimizing Data from Two NCDR Registries - 2024 Quality Summit Presentation (Non-CE)
Pumped Up for Heart Failure- 2024 Quality Summit Presentation (Non-CE)
Use of NCDR Data in Physician Contracts- 2024 Quality Summit Presentation (Non-CE)
Mitigating AKI – The Struggle is REAL- 2024 Quality Summit Presentation (Non-CE)
Atrial Fibrillation Energy Sources and Ablation Approaches – Who Gets What? - 2024 Quality Summit Presentation (Non-CE)
The New Dashboard – Bells & Whistles Galore- 2024 Quality Summit Presentation (Non-CE)
Why Go It Alone? Navigate Your Hospital System on an ACC Accreditation Journey- 2024 Quality Summit Presentation (Non-CE)
Best Practices in Mortality Review - 2024 Quality Summit Presentation (Non-CE)
Reviewing the Data: Post LAAO Antithrombotic Therapy- 2024 Quality Summit Presentation (Non-CE)
Atrial Fibrillation 2023 Guideline – Be in the Know! - 2024 Quality Summit Presentation (Non-CE)
Process Improvement: Initial ECG Review and Interpretation of Guideline Recommendations - 2024 Quality Summit Presentation (Non-CE)
Sneak Peek: Jump into the Driver’s Seat of the New CPC Accreditation Model - 2024 Quality Summit Presentation (Non-CE)
Advancing Transparency and Accountability Through Public Reporting- 2024 Quality Summit Presentation (Non-CE)
Advanced Imaging – What Are They Looking At & Why? - 2024 Quality Summit Presentation (Non-CE)
Keeping Pace - 2024 Quality Summit Presentation (Non-CE)
Residual Leaks: Post LAAO Imaging - 2024 Quality Summit Presentation (Non-CE)
Talk to the Experts for KCCQ Completion and Nurse Led Sedation Implementation - 2024 Quality Summit Presentation (Non-CE)
Hitting All the Benchmarks: Advanced Practice Nurses Paving the Way for Data Driven Quality Initiatives - 2024 Quality Summit Presentation (Non-CE)
Operational Considerations for Both Hospitals and ASCs - 2024 Quality Summit Presentation (Non-CE)
Meds to Beds: Enhancing Patient Care by Changing Culture - 2024 Quality Summit Presentation (Non-CE)
Same-day Discharge & Hospital Throughput – Insights from Your Peers - 2024 Quality Summit Presentation (Non-CE)
Data Abstraction Quality – Lessons from Your Peers - 2024 Quality Summit Presentation (Non-CE)
TVT Data Collection-It’s Science - 2024 Quality Summit Presentation (Non-CE)
Driving Results: Interventional & Electrophysiology Growth - 2024 Quality Summit Presentation (Non-CE)
The Career Path No One Told Me About – How I Landed Here - 2024 Quality Summit Presentation (Non-CE)
Showcase your Team’s Quality Achievements Quality Summit Wrap-Up - 2024 Quality Summit Presentation (Non-CE)
2024 Quality Summit ePosters (Non-CE) - LAAO Registry
2024 Quality Summit ePosters (Non-CE) - AFIB Registry
2024 Quality Summit ePosters (Non-CE) - EPDIR Registry
2024 Quality Summit ePosters (Non-CE) - CathPCI Registry
2024 Quality Summit ePosters (Non-CE) - Accreditation Registry
2024 Quality Summit ePosters (Non-CE) - General Quality Improvement
1024-Seq#7045(Diagnostic Coronary Angiography Procedure)
1024-Major or Disabling Bleeding
1024-Seq# 14732 Shared Decision Making
1024-Public Reporting
1024-Section N. Intra/Post-Procedure Events
1024-Adjunctive Ablation Lesions, Seq. # 7165 AFib Ablation Registry - v2.0
1024-Seq. 15460 (Shared Decision Making) v3.1
Overview of the New eReports Health Systems Dashboard - Non-CE
0824 - Sequence # 9040| Heart Failure
0824 - Sequence # 7850 | Patient Centered Reason for Delay
0824 - Inclusion - Exclusion Criteria
0824 - HIS vs CS Lead Individual Evaluation
0824 - Section N | Intra - Post Procedure Events
0824 - Sequence # 12153 - 9002 | Intra or Post-Procedure Event - Occurred
0824 - Sequence #9002 | Intra and Post-Procedure Events Occurred - Bleeding - Genitourinary
0624 - Sequence # 9080 | Hemorrhage (non-access site)
0624 - Sequence # 15453 | Risk Stratification
0624 - Inclusion/Exclusion Criteria
0624 - Section N. | Intra and Post-Procedure Events
0624 - Sequence # 4410 | Attempt at Atrial Fibrillation Termination
0624 - Sequence # 13700 | Low Flow
CV ASC Registry Education
0424 - Sequence #4630 (Cardiac Arrest Out of Healthcare Facility)
0424 - Sequence # 10205 (Discharge Medication Prescribed)
0424 - Sequence #3226 (Ischemic Heart Disease)
0424 - Sequence # 12153 | Intra or Post Procedure Events
0424 - Aortic Valve Reintervention
0424 - Metric 47 | Proportion of CRT-D Patients That Fulfill Class IIa Guideline Recommendation
0424 - Inclusion Criteria
Transcatheter Valve (TCV) Certification Overview - CE
Transcatheter Valve (TCV) Certification Overview - Non-CE
Transcatheter Valve (TCV) Certification Tool Orientation - CE
Transcatheter Valve (TCV) Certification Tool Orientation - Non-CE
2023 Quality Summit CE
The Viability of Heart Failure Virtual Clinics - 2023 Quality Summit Presentation (Non-CE)
Synthesizing Guidelines Into Action at the Bedside - 2023 Quality Summit Presentation (Non-CE)
Return on Investment: Finding Value in Accreditation - 2023 Quality Summit Presentation (Non-CE)
Quality-of-Life (AFEQT) Questionnaire – How Relevant is it? - 2023 Quality Summit Presentation (Non-CE)
Paving the Way to Resolution of AFib From Medication to Ablation - 2023 Quality Summit Presentation (Non-CE)
Navigating Same-Day PCI Discharges - 2023 Quality Summit Presentation (Non-CE)
Tricks of the Trade—Easing the Burden of Data Abstraction - 2023 Quality Summit Presentation (Non-CE)
Bridging Best Practices into Quality Improvement - 2023 Quality Summit Presentation (Non-CE)
Using the Guidelines to Increase Patient Throughput and Decrease Cost of Care - 2023 Quality Summit Presentation (Non-CE)
Building Best Practices to Drive Quality Improvement - 2023 Quality Summit Presentation (Non-CE)
Building a State Cardiac System of Care - 2023 Quality Summit Presentation (Non-CE)
Morning Coffee and Conversation with NCDR Experts - 2023 Quality Summit presentation (Non-CE)
A Breezy Conversation with Accreditation Experts - 2023 Quality Summit Presentation (Non-CE)
Afternoon Tea and Talk with NCDR Experts - 2023 Quality Summit presentation (Non-CE)
Appropriate Use Criteria (AUC) – What Does it All Mean? - 2023 Quality Summit Presentation (Non-CE)
What Really Matters with His Bundle and LBBB Pacing? - 2023 Quality Summit Presentation (Non-CE)
Shared Decision Making for Primary Prevention ICDs – Is It Necessary? - 2023 Quality Summit Presentation (Non-CE)
Opening Plenary/The Ralph G. Brindis Keynote: A Winning Strategy: Unleash Human Potential of the Workforce to Advance Quality and Safety - 2023 Quality Summit Presentation (Non-CE)
How to Navigate Quality in the Face of Corporate Medicine - 2023 Quality Summit Presentation (Non-CE)
Cardiovascular Disease Prevention at the Population Level - 2023 Quality Summit Presentation (Non-CE)
AI and the Care of the CV Patient - 2023 Quality Summit Presentation (Non-CE)
Creating a Culture of Health Equity--The Role of Providers, Patients, and Community - 2023 Quality Summit Presentation (Non-CE)
LAAO Imaging: The Changing Landscape of Imaging Modalities - 2023 Quality Summit Presentation (Non-CE)
Antithrombotic Therapy After LAAO: Changes in Care - 2023 Quality Summit Presentation (Non-CE)
Keeping Registries and Accreditation a Focus with Limited Resources - 2023 Quality Summit Presentation (Non-CE)
Staying Connected When Working Anywhere - 2023 Quality Summit Presentation (Non-CE)
Hold On to Your Hat to Hear About New Techniques in Transcatheter Procedures - 2023 Quality Summit Presentation (Non-CE)
Everything You Always Wanted to Know About KCCQ But Didn’t Know Who to Ask - 2023 Quality Summit Presentation (Non-CE)
It Takes a Village to Care for TVT Nation! - 2023 Quality Summit Presentation (Non-CE)
2023 Quality Summit ePosters (Non-CE) - Accreditation
2023 Quality Summit ePosters (Non-CE) - CathPCI Registry
2023 Quality Summit ePosters (Non-CE) - Chest Pain-MI Registry
2023 Quality Summit ePosters (Non-CE) - EP Device Implant Registry
2023 Quality Summit ePosters (Non-CE) - General Quality Improvement
2023 Quality Summit ePosters (Non-CE) - LAAO Registry
2023 Quality Summit ePosters (Non-CE) - STS/ACC TVT Registry
0224 - Sequence # 4040 | CHADS-VASc Thromboembolic Event
0224 - Sequence # 4560 | Currently on Dialysis and Intra and Post Procedure Event | New Requirement for Dialysis
0224 - Sequence # 15521 | Left Ventricular EF Assessed and Sequence # 12307 | LVEF Measurement
0224 - Metric 26 | Device Based Therapy Guidelines and AUC
0224 - Sequence # 5058 | Procedure End Time
0224 - Sequence # 4030 | CHA2DS2-VASc - Stroke
0224 - Sequence # 10116 | Cardiac Rehabilitation Referral
Medication Review: DOACs vs Warfarin - CE
Medication Review: DOACs vs Warfarin Non-CE
Heart Failure Accreditation Overview - CE
Heart Failure Accreditation Overview Non-CE
1223 - Cause of 1130 and 1140 Errors
1223 - Sequence # 10116 Cardiac Rehabilitation Referral
1223 -Sequence # 7175 | Transseptal Catheterization
1223 - Sequence # 7630 | Coronary Sinus/Left Ventricular (CS/LV) Lead | Metric 10 - Failure to Place CS/LV Lead
1223 - Sequence # 15490 | Cerebral Performance Category (CPC) Score
1223 - Sequence # 4025 | CHA2DS2-VASc Diabetes Mellitus
1223 - Sequence # 3170 | Cardiomyopathy & Sequence # 3175 | Cardiomyopathy History
Heart Failure Accreditation Tool Orientation - CE
Heart Failure Accreditation Tool Orientation Non - CE
1023 -Inclusion Criteria
1023 - Sequence # 8020 | Lesion Length
1023 - Sequence # 7135 | Coding Current Ablation Strategies
1023 -Sequence # 14731 | Reason Pacing Indicated
1023 -Sequence # 15510 | Conditional History - Cancer
1023 -Sequence # 4020 | CHA2DS2-VASc Hypertension
1023 - Sequence # 4041 | Pre-Procedure Medications
Understanding Guideline Metrics - CE
Understanding Guideline Metrics - Non-CE
Start Here - CE
Start Here - Non-CE
Data Quality Report (DQR) - Quality Assurance and Workflow - CE
Data Quality Report (DQR) - Quality Assurance and Workflow - Non-CE
0823 - Metric 307 | Patients With Acceptable Quality of Life Outcome at 30 Days Based on KCCQ Summary Score
0823 - Sequence # 7845 | First Device Activation Time
0823 - Inclusion Criteria
0823 - Sequence # 7010 | PPM Pacemaker to CRT-D
0823 - Sequence # 15452 | Canadian Study of Health and Aging (CSHA) Clinical Frailty Scale
0823 - Sequence # 14851 | Follow-up Interval
0823 - Sequence # 6010 | Systemic Ventricular Systolic Pressure
Cardiac Catheterization Lab (CCL) Accreditation Overview - CE
Cardiac Catheterization Lab (CCL) Accreditation Overview Non-CE
Quality Check Essentials - CE
Quality Check Essentials - Non-CE
Cardiovascular Program Coordinator Course - CE
Cardiovascular Program Coordinator Course Non-CE
0623 - Data Submission Process
0623 - Sequence # 7825 | PCI Indication
0623 - Sequence # 4030 | CHADS-VASc - Stroke
0623 - Sequence # 7010 | Procedure Type
0623 - Metric 46: P2Y12 Inhibitors at Discharge
0623 - Sequence # 4015 | CHA2DS2-VASc Left Ventricular Dysfunction
0623 - General Submission Population
An NCDR Overview - CE
An NCDR Overview-Non-CE
0423 - Sequence # 9002 | Intra/Post-Procedure Events Occurred: Cardiac Arrest-4180
0423 - Sequence # 4025 | CHADS-VASc - Diabetes Mellitus
0423 - Metric 26 | Device Based Therapy Guidelines and AUC
0423 - Sequence # 9002 | Intra/Post-Procedure Events Occurred: Cardiac Arrest
0423 - Sequence # 4010 | CHA2DS2-VASc NYHA Functional Classification
0423 - Sequence # 8090 | Bleeding Events
2022 Quality Summit ePosters (Non-CE) - Cardiac Cath Lab Accreditation
2022 Quality Summit ePosters (Non-CE) - Chest Pain Center Accreditation
2022 Quality Summit ePosters (Non-CE) - Electrophysiology Accreditation
2022 Quality Summit ePosters (Non-CE) - Heart Failure Accreditation
2022 Quality Summit ePosters (Non-CE) - AFib Ablation Registry
2022 Quality Summit ePosters (Non-CE) - CathPCI Registry
2022 Quality Summit ePosters (Non-CE) - Chest Pain-MI Registry
2022 Quality Summit ePosters (Non-CE) - EP Device Implant Registry
2022 Quality Summit ePosters (Non-CE) - General Quality Improvement
2022 Quality Summit ePosters (Non-CE) - LAAO Registry
2022 Quality Summit ePosters (Non-CE) - STS/ACC TVT Registry
Bridging LAAO Data and Quality Improvement - 2022 Quality Summit presentation (Non-CE)
How to Project and Prepare for the Abstraction Burden of Follow Ups in a High Volume LAAO Registry™ Program - 2022 Quality Summit presentation (Non-CE)
Identifying Racial Disparities in Access to TAVR Procedures in a South Carolinian Safety-Net Hospital - 2022 Quality Summit presentation (Non-CE)
A Collaboration to Improve Low Compliance in the Utilization of Risk Score for NSTEMI Patients - 2022 Quality Summit presentation (Non-CE)
False Cath Lab Activations, But Are They a Bad Thing? - 2022 Quality Summit presentation (Non-CE)
ACC’s Global Quality Solutions - 2022 Quality Summit presentation (Non-CE)
Pioneering the 2022 Heart Failure Guidelines - 2022 Quality Summit presentation (Non-CE)
Conversation with the Experts — Session #1 - 2022 Quality Summit presentation (Non-CE)
Conversation with the Experts — Session #2 - 2022 Quality Summit presentation (Non-CE)
Building a Better Mousetrap: Leveraging Technology for Quality Improvement Process Improvement - 2022 Quality Summit presentation (Non-CE)
Building a Successful Structural Heart Program - 2022 Quality Summit presentation (Non-CE)
Cardiac Rehab – Improving Cardiac Rehab Referrals and Addressing the Cost And Revenue Impact - 2022 Quality Summit presentation (Non-CE)
Disruptions on the Horizons - Innovations in Patient-Reported and Social Determinants of Health Data Collection and Use - 2022 Quality Summit presentation (Non-CE)
Enhancing Recovery After Heart Transplant A Patient-Participation Approach to Co-Designing a New Pre-Habilitation Program - 2022 Quality Summit presentation (Non-CE)
Leveraging Your NCDR Data & Accreditation to Address Inequities of Care - 2022 Quality Summit presentation (Non-CE)
Mitigating Acute Kidney Injury – Learn from these Rockstars - 2022 Quality Summit presentation (Non-CE)
Opening Plenary The Ralph G. Brindis Keynote: Past, Present and Future Direction of NCDR and Accreditation Services - 2022 Quality Summit presentation (Non-CE)
Pacing down Hollywood Blvd. - 2022 Quality Summit presentation (Non-CE)
Post COVID 19 Response – Getting Back to the Basics - 2022 Quality Summit presentation (Non-CE)
Rebuilding the CV Team in the Wake of COVID - 19 - 2022 Quality Summit presentation (Non-CE)
So Many Ablation Strategies – How to Choose? - 2022 Quality Summit presentation (Non-CE)
The Value of EP Device Registry Data: Impacting Care Delivery with Data and Metrics - 2022 Quality Summit presentation (Non-CE)
You CAN Speak for the Data, We’ll Show You! - 2022 Quality Summit presentation (Non-CE)
CPMI + CPC = Synergy - 2022 Quality Summit presentation (Non-CE)
Toolkit to Success for TVT Programs Part 1 - 2022 Quality Summit presentation (Non-CE)
Toolkit to Success for TVT Programs Part 2 - 2022 Quality Summit presentation (Non-CE)
Putting Registry Data Into Action: Lessons Learned from the Vascular Quality Initiative - 2022 Quality Summit presentation (Non-CE)
Type II MI & MINOCA — Strategies for Success - 2022 Quality Summit presentation (Non-CE)
Risk Prediction and How the HAS-BLED/CHA2DS2-VASC Assessments and Scores Interconnect- 2022 Quality Summit presentation (Non-CE)
Using a Collaborative Quality Improvement Registry to Improve Radiation Dose Reporting and Reduction: The BMC2 PCI Experience in Michigan - 2022 Quality Summit presentation (Non-CE)
Safe and Successful Medication Management Strategies and All Provider Communication for Patient Receiving an LAAO Device - 2022 Quality Summit presentation (Non-CE)
Promoting Awareness of Heart Attack Symptoms and Responsive Action - 2022 Quality Summit presentation (Non-CE)
Using a Multi-Disciplinary Virtual Consultation Platform to Enhance Community Referrals for Developing a Cardiac Amyloidosis Program (Enhance-refCA) - 2022 Quality Summit presentation (Non-CE)
What’s New What’s Different? - 2022 Quality Summit presentation (Non-CE)
Navigating Same-Day Discharge — Decreasing Readmissions and Improving Satisfaction - 2022 Quality Summit presentation (Non-CE)
Observation Management — Keys to a Successful ACS Observation Program - 2022 Quality Summit presentation (Non-CE)
Riding Out the Storm: Resilience Through Accreditation - 2022 Quality Summit presentation (Non-CE)
Why Clinical Frailty? - 2022 Quality Summit presentation (Non-CE)
Quality of Care Composite — One Stop Shopping - 2022 Quality Summit presentation (Non-CE)
Where to Go? The Quest for Registry Answers - 2022 Quality Summit presentation (Non-CE)
Quality Improvement Process in Response to NCDR Device Registry ICD Data - 2022 Quality Summit presentation (Non-CE)
Quality of Care Metric for the EP Device Implant Patient - 2022 Quality Summit presentation (Non-CE)
Shared Decision Making is Here to Stay - 2022 Quality Summit presentation (Non-CE)
Shared Decision Making Leads to Improved Patient Outcomes - 2022 Quality Summit presentation (Non-CE)
Streamlining Same-Day Planning for Left Atrial Appendage Closure Procedure with Transesophageal Echocardiography - 2022 Quality Summit presentation (Non-CE)
Cumulative Effects of Contrast Use in Pediatric Cases - 2022 Quality Summit presentation (Non-CE)
1121 - ACPC Quality Network Learning Session - MOC Part 4, Change Management and Metric 034 Overview
ACPC Quality Network Learning Session 2024-Q1 – Program Updates, MOC Part 4 and Metric 028 Overview
NCDR - Inpatient Registry Overviews - CE
0223 - Sequence # 7400 | Indications for Cath Lab Visit
0223 - Sequence # 4020 | CHADS-VASc-Hypertension
0223 - Metric 27 & the AUC
0223 - Coding Aortic Valve Regurgitation: Post-Procedure and Follow-Up
0223 - Sequence # 4005 | CHA2DS2-VASc Congestive Heart Failure
0223 - Inclusion Criteria
NCDR eReports Health Systems Dashboard Review - CE
NCDR eReports Health Systems Dashboard Review - Non-CE
1222 - Sequence # 4005 - 4110 | CHADS-VASc - CHF / NYHA Classification
1222 - Sequence # 4280 | Syncope
1222 - Sequence # 13765 | 12 Lead Electrocardiogram Findings
1222 - Sequence # 4110 - 4115 | HAS-BLED Drugs - Antiplatelet & NSAID
1222 - Sequence # 3231 | Rheumatic Heart Disease & Sequence # 3235 | Seizure Disorder
1222 - Inclusion Criteria
1222 - Section H. Coronary Anatomy
1122 - Sequence # 4110 - 4115 | HAS-BLED Drug - Antiplatelet & NSAID
1122 - Appropriate Use Criteria Metrics
1122 - Coding Multiple Procedures Under the Same Episode of Care
1122 - Sequence # 4105 | HAS-BLED Alcohol
1122 - Sequence # 6010 | Systemic Ventricular Systolic Pressure
1122 - Metric 37 | First Medical Contact - Device Time
1122 - Sequence # 7511 | Native Vessel Adjunctive Measurements Obtained
1022 - Sequence # 4105 | HAS-BLED Alcohol
1022 - Appropriate Use Criteria Metrics
1022 - Eligibility for Follow-Up Metric 307 | Patients with Acceptable Quality of Life Outcome at 30 Days Based on the KCCQ Summary Score
1022 - Sequence # 14732 | Shared Decision Making
1022 - Intra and Post Procedure Events
1022 - Inclusion | Exclusion Criteria
1022 - Sequence # 7835 | STEMI or STEMI Equivalent First Noted
0922 - Sequence # 4100 | HAS-BLED Risk Score: HAS-BLED Labile INR
0922 - Metric 18 | Risk Standardized Complications (All Defibrillator Implants)
0922 - Star Ratings Eligibility for Public Reporting
0922 - Sequence # 4100 | HAS-BLED Labile INR
0922 - Sequence # 8071 | Coronary Artery Compression
0922 - Sequence # 10207 | Medications Prescribed at Discharge - Statin Dose
0922 - Sequence # 5032 | Electrocardiac Assessment Results
Heart Failure (HF) Accreditation Conformance Database and Calculated Measures - CE
Heart Failure (HF) Accreditation Conformance Database and Calculated Measures Non-CE
0822 - Sequence # 8008 | Previously Treated Lesion
0822 - Sequence # 12342 Episode Event | Metric 45 In-Hospital Risk Standardized Rate of Bleeding [STEMI (pre-admit) and NSTEMI patients]
0822 - Sequence # 8070 | New Requirement for Dialysis
0822 - Sequence # 4095 | HAS BLED - Bleeding
0822 - Metric 307 | Patients with Acceptable Quality of Life Outcome at 30 Days Based on KCCQ Summary Score
0822 - Sequence # 10205 Discharge Medications Prescribed | Metric 4 - Proportion of ICD/CRT-D Implant Patients with LVSD, who were Prescribed ACE-I, ARB, or ARN
0822 - Sequence # 4095 | HAS-BLED Bleeding
0722 - Going Beyond the Obvious in Metric Review - Part 2
0722 - Sequence # 8130 | RBC Transfusion
0722 - Sequence # 4070 | HAS BLED - Stroke
0722 - Sequence # 7065 | Concomitant Procedure
0722 - Metric 26 and Appropriate Use Criteria (AUC)
0722 - Sequence # 7210 & 7220 | Cumulative Air Kerma and Dose Area Product
0622 - AUC - Acute Coronary Syndrome
0622 - Going Beyond the Obvious in Metric Review
0622 - Sequence # 8075 | Airway Event Requiring Escalation of Care
0622 - Sequence # 4055 | HAS BLED - Hypertension (Uncontrolled)
0622 - Sequence # 9002 | Intra/Post Procedure Events Occurred: Cardiac Perforation
0622 - Sequence # 4310 | Results of Angiography
0622 - Sequence # 5170 | Baseline Imaging Performed
Building Strong Relationships Between Hospitals and EMS - CE
Building Strong Relationships Between Hospitals and EMS - Non-CE
0522 - Sequence # 7400 | Indications for Cath Lab Visit
0522 - Sequence # 12295 | Thrombolytic | Metric 17 - Reperfusion Therapy
0522 - Sequence # 6060 | Qp/Qs Ratio
0522 - Metric 5 | Proportion of Left Atrial Appendage Occlusion Procedures Successful Excluding Those Procedures Cancelled
0522 - Sequence # 9002 | Intra/Post Procedure Events Occurred, Permanent Pacemaker
0522 - Metric 35 | Intra or Post Procedure Events and Metric 35
0522 - Sequence # 4070 | HAS-BLED Stroke
0422 - Metric 4 | Proportion of Left Atrial Appendage Occlusion Procedures Successful
0422 - Inclusion Criteria
0422 - Sequence # 7610 | PDA Minimum Luminal Diameter
0422 - Sequence # 14739 | His / Left Bundle Lead and Metric 31
0422 - Sequence # 13381 | Number of Diseased Vessels
0422 - Sequence # 4055 | HAS-BLED Hypertension (Uncontrolled)
0422 - Sequence # 8021 | (Severe Calcification)
0322 - LAA Device Removal During Base Procedure | Follow-Up Requirements
0322 - Inclusion Criteria
0322 - Sequence # 8140 | Other Vascular Complications Requiring Treatment
0322 - Sequence # 14739 | His/Bundle Pacing
0322 - Sequence # 13704 | Mitral Valve Disease
0322 - Inclusion Criteria | Re-do Pulmonary Vein Isolation
0322 - Sequence # 4561 | CSHA Clinical Frailty Scale
0222 - Inclusion Criteria of 2nd LAAO Procedure During Follow-Up Period
0222 - Metric 55 - Door-in | Door-out time
0222 - Sequence # 11101 | Post Dilitation of Transcatheter Pulmonary Valve
0222 - Sequence # 7630 and Metric 10 | Proportion of Defibrillator Lab Visits With an Unsuccessful Attempt to Place the Coronary Sinus/ Left Ventricular Lead
0222 - Sequence # 9002 | Intra/Post Procedure Events Occurred: (Vascular Complication - Minor)
0222 - Sequence # 9095 | Genitourinary Bleeding - Intra or Post-Procedure Event
0222 - Sequence #5263 | Prior Diagnostic Coronary Angiogram Without Intervention
0122 - Metric 34 | Proportion of Defibrillator Patients with a Primary Tachycardia Indication & a Bradycardia Indication
0122 - Sequence # 10205 | Discharge Medications Prescribed - ARNI
0122 - Sequence # 4410 & 4420 | Attempt at Atrial Fibrillation Termination/DC Cardioversion
0122 - Sequence # 4410 | Attempt at Atrial Fibrillation Termination
0122 - Sequence # 7258 | Aortic Valvuloplasty Post Dilation Regurgitation
0122 - Sequence # 7325 | Arterial Cross Over
1221 - Fixing Error 1130
1221 - Metric 37 | First Medical Contact to Device Time
1221 - Sequence # 13331 | Anesthesia Type
1221 - Sequence # 14719 | Ventricular Fibrillation
1221 - Sequence # 4410 | Attempt at Atrial Fibrillation Termination
1221 - Sequence # 8000 | Cardiac Arrest
1121 - Intra/Post-Procedure Events | Coding Pericardial Effusion Complication
1121 - Public Reporting
1121 - Sequence # 10205 | Discharge Medications Prescribed - ARNI
1121 - Sequence # 7505, 7507, 7508 | Coronary Anatomy
1121 - Sequence # 7620 | PDA Classification
1121 - Sequence # 9002 | Intra/Post-Procedure Events Occurred - Bleeding: Hematoma at Access Site
1021 - Sequence # 7180 & 7190 | Cardioversion (CD) Performed During Procedure
1021 - Sequence # 7400 & 7405 | Indications for Cath Lab Visit & Chest Pain Symptom Assessment
1021 - Sequence # 8055 | Device Embolization
1021 - Sequence # 9002 | Intra/Post-Procedure Events Occurred - Ischemic Stroke
0921 - Sequence # 12447 | STEMI Type
0921 - Sequence # 13025 | Follow-up Cause of Death
0921 - Sequence # 13423 | Aortic Valve Calcification Severity and Sequence # 13471 | Aortic Valve Annular Calcification
0921 - Sequence # 4001 | Heart Failure
0921 - Sequence # 4440 | Attempt at Atrial Fibrillation Termination/Surgical Ablation
0921 - Sequence # 7010 | Procedure Type
0921 - Sequence # 8035 | Tamponade Requiring Pericardial Drainage
0821 – Metric 56 | Time to Primary PCI Among Transferred Patients
0821 - Sequence # 14732 | Shared Decision Making
0821 - Sequence # 7002 | Procedure Start Time
0821 - Sequence # 7135 | Current Ablation Strategy/Convergent
0821 - Sequence # 8130 | RBC Transfusion
0821 – v3 | Provider Maintenance and Remediation
0721 - Metric # 46 | P2Y12- Inhibitor at Discharge
0721 - Sequence # 10200 - 10205 | Discharge Medications
0721 - Sequence # 14732 | Shared Decision Making
0721 - Sequence # 14737 | Primary Bradycardia Indication Present
0721 - Sequence # 7295 & 7296 | Procedure Aborted/Procedure Aborted, Reason
0721 - Sequence # 7650 | PDA Closure - Outcome of Device
0621 - Seq# 14729 | Primary Tachycardia Indication Present
0621 - Sequence # 10025 | Discharge Atrial Rhythm
0621 - Sequence # 13160 - 13175 | Follow Up Event: Device Migration and Device Systemic Embolism
0621 - Sequence # 4026 | Single Ventricle
0621 - Sequence # 7065 | Concomitant Procedures Performed
0621 - Sequence # 7845 | First Device Activation Date/Time
0521 - Follow-Up One Year
0521 - Sequence # 13165 | Follow-Up Events: Systemic Thromboembolism
0521 - v2.3 Inclusion Criteria
0521 - Sequence # 3200 | Chronic Lung Disease
0521 - Sequence # 9080 | Hemorrhage (Non-Access Site), Systemic Events
0521 - Metric # 8 | Aspirin at Discharge
0421 - Appropriate Use Criteria
0421 - Sequence # 12360 | Patient Type
0421 - Sequence # 14719 | Ventricular Fibrillation
0421 - Sequence # 4005 | CHA2DS2 - VASC Congestive Heart Failure
0421 - Sequence # 4600 | Left Atrial Appendage Intervention
0421 - Sequence # 9002 | (Intra/Post-Procedure Events Occurred - Vascular Complication - Minor)
0321 - Risk Standardized Mortality
0321 - Sequence # 10115 | Hospice Care
0321 - Sequence # 4065 | HAS-BLED - Abnormal Liver Function
0321 - Sequence # 4065 | HAS-BLED Risk Score - Abnormal Liver Function
0321 - Sequence # 8075 | Airway Event Requiring Escalation of Care
0321 - Sequence # 9002 | (Intra/Post-Procedure Events Occurred - Bleeding: Access Site)
0221 - Inclusion Criteria
0221 - Inclusion Criteria | Trial Study Populations
0221 - Sequence # 4060 | HAS-BLED - Abnormal Renal Function
0221 - Sequence # 5047 & 5048 | Procedure Start Date/Time
0221 - Sequence # 7410 & 7415 | Cardiovascular Instability/Instability Type
0221 - Sequence 10200 & 10205 | Discharge Medications
0121 - Metric 56 | Time to Primary PCI Among Transferred Patients
0121 - Sequence # 10116 | Cardiac Rehabilitation Referral
0121 - Sequence # 4015 | CHA2DS2-VASc LV Dysfunction
0121 - Sequence # 4060 | HAS-BLED - Abnormal Renal Function
0121 - Sequence # 5057 & 5058 | Procedure End Date/Time
1220 - Metric 55 | Door-In Door-Out Time
1220 - Sequence # 5004 | Pulmonary Valvuloplasty
1220 - Sequence # 7511 | Adjunctive Measurements Performed
1220 - Sequence # 9185 | Hematoma at Access Site
1120 - Metric 34 | Aspirin at Discharge
1120 - Sequence # 3080 | Prior Cardiac Surgery
1120 - Sequence # 4110 & 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS
1120 - Sequence # 4110 and 4115 | HAS-BLED Drugs - Antiplatelet & NSAIDS
1120 - Sequence # 9275 | Packed Red Blood Cell Transfusion
1020 - Metric 56 | Time to Primary PCI Among Transferred Patients
1020 - Sequence # 4410 & 4415 | Attempt at Atrial Fibrillation Termination and Pharmacologic Cardioversion
1020 - Sequence # 5010 & 5001 | Coding a PFO Closure when Performed with an ASD Closure
1020 - Sequence # 7810 & 10117 | LOC - PCI and LOC - Discharge
0920 - Sequence # 5130 | Fluoroscopy Time
0920 - Sequence # 5200 | Stress Test Performed
0920 - Sequence # 9105 | Phrenic Nerve Damage
0820 - Sequence # 12360 | Patient Type
0820 - Sequence # 5160 | Inotrope
0820 - Sequence # 7225 and 7250 | Intraprocedure Anticoagulation & Other
0820 - Sequence # 7295 | Procedure Aborted - Metric # 6
0720 - Sequence # 4565 & 4570 | (Cardiomyopathy & CM Type)
0720 - Sequence # 7035 | Indication for LAA Occlusion
0720 - Sequence # 8210 | Intra/Post-Procedure Events - Pneumothorax
0620 - Metric # 1 | Proportion of Patients Undergoing AFA w/Class I or Class II Guideline Based Indication
0620 - Metric 24 | Cardiac Catheterization Adverse Events
0620 - Metric 36 | High Intensity Statin at Discharge
0620 - Sequence # 14731 | Reason Pacing Indicated v2.3
0620 - Sequence # 9146 | Significant Coronary Artery Dissection
0520 - Sequence # 13050 | 45 Day Follow-Up - Transesophageal Echo Performed
0520 - Sequence # 7080/7090 | Atrial Septal Defect Closure Procedure
0520 - Sequence # 7820 | Multivessel Disease
0520 - Sequence # 7845 | First Device Activation Date and Time
0520 - Sequence # 9025 | Bradycardia Adverse Events
0420 - Sequence # 12360 | Patient Type
0420 - Sequence # 4026 | Single Ventricle
0420 - Sequence # 4045 | CHA2DS2-VASc Vascular Disease
0420 - Sequence # 7010 | Procedure Type
0420 - Sequence # 7065 | Concomitant Procedures
0320 - Sequence # 10116 | Cardiac Rehab Referral
0320 - Sequence # 10116/Metric 21 | Cardiac Rehab Referral
0320 - Sequence # 13015 | Follow-Up Status: Deceased
0320 - Sequence # 7155 | Number of Veins Isolated
0320 - Sequence # 7630 and Metric 10 | Failure to Place CS/LV Lead
0320 - Sequence # 8070 | New Requirement for Dialysis
0220 - Inclusion Criteria
0220 - Sequence # 10200 & 10205 | Discharge Medications
0220 - Sequence # 3222 | Heart Failure
0220 - Sequence # 7305 | Device Margin Residual Leak
0120 - Metric # 40 | PCI In-Hospital Risk Standardized Bleeding
0220 - Sequence # 7850 | Patient Centered Reason for Delay
0120 - Sequence # 13060 | Follow-Up: Atrial Thrombus Detected
0120 - Sequence # 6985 - 6990 | Pre-Procedure Medication Administered
0120 - Sequence # 8160 | Unplanned Cardiac Surgery
CathPCI Registry Metric #45 - Non-CE
Engaging the Clinical Team to Develop a Quality Centered Program - Non-CE
Getting Acquainted with the Cath PCI v5 Dataset
CathPCI Registry Metric #40 Risk Standardized Bleeding - Non-CE
How Gaps in the Guidelines are Addressed in the AUC - Non-CE
3.0 New Version - 2020 Quality Summit presentation (Non-CE)
ACC Reduce the Risk: PCI Bleed Quality Campaign – What the Data Show - 2020 Quality Summit presentation (Non-CE)
AFib Ablation “State of the Art” - 2020 Quality Summit presentation (Non-CE)
CathPCI & Chest Pain – MI Registry: Supporting Patients, Providers & Organizations - 2020 Quality Summit presentation (Non-CE)
Collaboration on Improving the Efficiency of Data Abstraction - 2020 Quality Summit presentation (Non-CE)
Coming Soon: ICD Registry Version 2.3 Update! - 2020 Quality Summit presentation (Non-CE)
Cutting Edge Care of PDA in Premature Low Birth Wight Babies - 2021 Quality Summit presentation (Non-CE)
2021 Onward & Upward! - 2021 Quality Summit presentation (Non-CE)
Cardiac Rehabilitation in the Inpatient Setting: Bridging the Gap - 2021 Quality Summit presentation (Non-CE)
The Economics of Accreditation - 2021 Quality Summit presentation (Non-CE)
Take your EMS-Hospital Relationship to the Next Level: It's Not a Date, It's a Marriage - 2021 Quality Summit presentation (Non CE)
The Ralph G. Brindis Lecture & Closing - 2021 Quality Summit presentation (Non-CE)
Changing Culture - 2021 Quality Summit presentation (Non-CE)
LAAO Procedure Decision Making and Patient Selection - 2021 Quality Summit presentation (Non-CE)
12 Lead ECG Training to Ensure Optimal Triage and Treatment of Patients with Acute Coronary Syndromes and Life-Threating Arrhythmias - 2021 Quality Summit presentation (Non-CE)
Best Practice Sharing - Using Data to Drive Improvement - 2021 Quality Summit presentation (Non-CE)
The Detail is in the Documentation- Risk Score and Adverse Event Coding - 2021 Quality Summit presentation (Non-CE)
Everything You Always Wanted to Know About the Composite Risk Model - 2021 Quality Summit presentation (Non-CE)
The NCDR and SVS VQI Registry Collaboration: Providing Data, Resources and Peer-to-Peer Interactions to Help Improve Quality of Care - 2021 Quality Summit presentation (Non-CE)
Own Your Data, Dollars and Outcome: Centralized Registry Pros and Cons from a Leadership Perspective - 2021 Quality Summit presentation (Non-CE)
Selling Quality ...Articulating the Valve Proposition and ROI of CV Registries and Accreditation - 2021 Quality Summit presentation (Non-CE)
Troubleshooting Your Way to Accurate Appropriate Use Criteria Indications - 2021 Quality Summit presentation (Non-CE)
What Drives Patient Selection for Afib Ablation - 2021 Quality Summit presentation (Non-CE)
Troponin Assays the 411 - 2021 Quality Summit presentation (Non-CE)
Chest Pain Management — How to Get the Compass to Stop Spinning and Find Direction - 2021 Quality Summit presentation (Non-CE)
Who Knew the Tricuspid Valve Would Be So Interesting? - 2021 Quality Summit presentation (Non-CE)
Isn’t Informed Consent the Same as SDM? - 2021 Quality Summit presentation (Non-CE)
Exploring the AFib Ablation Procedure - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — Dashboard Mania - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — A Participants' Perspective - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — Quality Improvement in Action - 2021 Quality Summit presentation (Non-CE)
Conversation with the Experts — NCDR Fundamentals - 2021 Quality Summit presentation (Non-CE)
The New Normal: Innovative Approaches to Managing and Measuring Your Accreditation and Registry Workplace - 2021 Quality Summit presentation (Non-CE)
New Tools in the Toolbox to Fix the Pulmonary Valve - 2021 Quality Summit presentation (Non-CE)
A Case Study - CRT-P or CRT-D? - 2021 Quality Summit presentation (Non-CE)
Current and Future Role of Innovation in Healthcare - 2021 Quality Summit presentation (Non-CE)
Chest Pain-MI Registry: How to Navigate Rough Waters and Find Smooth Sailing - 2021 Quality Summit presentation (Non-CE)
Fine Tuning Processes - Best Practice Sharing - 2021 Quality Summit presentation (Non-CE)
Mississippi State of Mind - 2021 Quality Summit presentation (Non-CE)
Update on the Risk Model - 2021 Quality Summit presentation (Non-CE)
Pacing Indications/Guidelines and Pacing Modes - 2021 Quality Summit presentation (Non-CE)
Reduce the Risk: PCI Bleed Campaign Achievement Celebration and a Look at YOUR Next Steps - - 2021 Quality Summit presentation (Non-CE)
Sharing the Value of Registry Data - 2021 Quality Summit presentation (Non-CE)
PulsePoint in Cape Girardeau, Missouri: A Community Collaborate Project to Enhance Early Heart Attack Care - 2021 Quality Summit presentation (Non-CE)
The Midwest STEMI Consortium - 2021 Quality Summit presentation (Non-CE)
What’s New What’s Different? - 2021 Quality Summit presentation (Non-CE)
Hierarchical Risk Modeling – You Can Get This! - 2020 Quality Summit presentation (Non-CE)
IMPACT Data Can Unleash Program Excellence - 2020 Quality Summit presentation (Non-CE)
New Kids on the Block — The Update Populations of the Chest Pain – MI - 2020 Quality Summit presentation (Non-CE)
Patient Navigator Program: Focus MI — It Takes a Village Lessons Learned - 2020 Quality Summit presentation (Non-CE)
Post Procedure Anticoagulation Medication Strategies and Variations - 2020 Quality Summit presentation (Non-CE)
Quality Care in the COVID-19 Era — The Best Practices Ping Pong Match - 2020 Quality Summit presentation (Non-CE)
Quality Improvement Application – Connecting the Clinical Team - 2020 Quality Summit presentation (Non-CE)
Shared Decision Making - 2020 Quality Summit presentation (Non-CE)
The COVID-19 Pandemic: Part 1 - 2020 Quality Summit presentation (Non-CE)
The COVID-19 Pandemic: Part 2 - 2020 Quality Summit presentation (Non-CE)
The Roadmap to Excellence Accreditation will Help! - 2020 Quality Summit presentation (Non-CE)
The Value of Chest Pain Center Accreditation and Creating a Culture of Process Improvement - 2020 Quality Summit presentation (Non-CE)
The Why and How of Selecting an ICD Lead and Location - 2020 Quality Summit presentation (Non-CE)
TRANSFORM: LDL – C Risk, an ACC Initiative to Reduce ASCVD Risk Among Secondary Prevention Patients within the PINNACLE Registry - 2020 Quality Summit presentation (Non-CE)
Understanding the LAAO Registry Follow Up Processes - 2020 Quality Summit presentation (Non-CE)
Universal Principles of Leading Change Through ACC Quality Campaigns - 2020 Quality Summit presentation (Non-CE)
What’s New What’s Old in TVT Metrics - 2020 Quality Summit presentation (Non-CE)
WOW! Look What We’ve Done with Telemedicine as the New normal - 2020 Quality Summit presentation (Non-CE)
Introduction to Chest Pain - MI Registry v3 - Non-CE
Introduction to NCDR Inpatient Registry Overviews - Non-CE
Mastering Composite Performance Measures - Non-CE
NCDR Dashboard Functionality - All Registries - Non-CE
NCDR Dashboard Functionality: IMPACT Registry LAAO Registry - Non-CE
NCDR Domestic and International Onboarding - Non-CE
NCDR Inpatient Registry Overviews - Atrial Fibrillation Ablation Registry - Non-CE
NCDR Inpatient Registry Overviews - CathPCI Registry - Non-CE
NCDR Inpatient Registry Overviews - CP-MI Registry - Non-CE
NCDR Inpatient Registry Overviews - ICD Registry - Non-CE
NCDR Inpatient Registry Overviews - IMPACT Registry - Non-CE
NCDR Inpatient Registry Overviews - LAAO Registry - Non-CE
NCDR Inpatient Registry Overviews - STS/ACC TVT Registry - Non-CE
Reduce the Risk: PCI Bleed Quality Campaign - Non-CE
Regional Time Sensitive Care Coalitions Course - Non-CE
Understanding the LAAO Registry Follow-Up Process - Non-CE
What is a DQR? Rationale and Training - Non-CE
How to Upload a .csv file into the Accreditation Conformance Database (ACD)
How to Update Contacts Within the Accreditation Tool
How to Upload and Attach Supporting Documents into the Tool
Important First Steps and Useful Information
Action Item #1: Complete All Information in the Administration Link
Chest Pain-MI v3.1 Education
LAAO v1.4 Education
STS/ACC TVT v3 Education
EP Device Implant v2.3 Education
Action Item #2: Know the 10 Step Process to Registry Success
Action Item #3: Utilize All Available NCDR Resources
Action Item #4: Know NCDR Terminology and Acronyms!
Action Item #5: Review Coding Unique to International Participants (For Global Participants Only)
An Introduction to NCDR’s New Dashboards - Non-CE